SIA
Schear Investment Advisers’s Eli Lilly LLY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.51M | Sell |
7,066
-251
| -3% | -$196K | 2.73% | 11 |
|
2025
Q1 | $6.04M | Sell |
7,317
-1,218
| -14% | -$1.01M | 3.48% | 5 |
|
2024
Q4 | $6.59M | Buy |
8,535
+139
| +2% | +$107K | 3.51% | 7 |
|
2024
Q3 | $7.44M | Buy |
8,396
+687
| +9% | +$609K | 4.6% | 2 |
|
2024
Q2 | $6.98M | Buy |
7,709
+98
| +1% | +$88.7K | 5.04% | 2 |
|
2024
Q1 | $5.92M | Sell |
7,611
-169
| -2% | -$131K | 4.75% | 3 |
|
2023
Q4 | $4.54M | Buy |
7,780
+13
| +0.2% | +$7.58K | 4.37% | 4 |
|
2023
Q3 | $4.17M | Sell |
7,767
-276
| -3% | -$148K | 4.5% | 3 |
|
2023
Q2 | $3.77M | Buy |
8,043
+213
| +3% | +$99.9K | 3.99% | 5 |
|
2023
Q1 | $2.69M | Buy |
7,830
+236
| +3% | +$81K | 3.22% | 5 |
|
2022
Q4 | $2.78M | Buy |
+7,594
| New | +$2.78M | 3.43% | 3 |
|